Mesoblast (MESO) Cost of Revenue: 2014-2025
Historic Cost of Revenue for Mesoblast (MESO) over the last 10 years, with Jun 2025 value amounting to $5.1 million.
- Mesoblast's Cost of Revenue fell 272.16% to -$19.0 million in Q2 2023 from the same period last year, while for Mar 2023 it was $30.0 million, marking a year-over-year increase of 12.41%. This contributed to the annual value of $5.1 million for FY2025, which is N/A change from last year.
- Latest data reveals that Mesoblast reported Cost of Revenue of $5.1 million as of FY2025, which was down 83.32% from $30.8 million recorded in FY2022.
- Mesoblast's 5-year Cost of Revenue high stood at $32.7 million for FY2021, and its period low was $5.1 million during FY2025.
- Over the past 1 years, Mesoblast's median Cost of Revenue value was $5.1 million (recorded in 2025), while the average stood at $5.1 million.
- In the last 5 years, Mesoblast's Cost of Revenue increased by 29.28% in 2021 and then dropped by 6.00% in 2022.
- Yearly analysis of 3 years shows Mesoblast's Cost of Revenue stood at $32.7 million in 2021, then fell by 6.00% to $30.8 million in 2022, then reached $5.1 million in 2025.